Ergocalciferol in Chronic Kidney Disease

Saint Louis VA Medical Center

Status: Completed

Conditions: Chronic Kidney Disease

Study type: Observational

Funder types: Other U.S. Federal agency

Identifiers

NCT00411294

ZA-01

Details and patient eligibility

About

To examine the effect of ergocalciferol treatment on 25-hydroxyvitamin D and PTH levels in patients with CKD stage 3 and 4

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with CKD stage 3 or 4 whose 25-hydroxyvitamin D levels are below 30 ng/ml and plasma intact PTH levels >70 pg/ml.

Exclusion criteria

• Patients who are on any form of active vitamin treatment